The clinical research of methylprednisolone on postoperative traumatic reaction of cervical spondylotic myelopathy

魏民,张伯勋,王岩,刘郑生,肖嵩华,陶笙
DOI: https://doi.org/10.3969/j.issn.1008-9926.2003.02.007
2003-01-01
Abstract:Aim To discuss the therapeutic effects of methylprednisolone on postoperative traumatic reaction of anterior decompressive operation of cervical spondylotic myelopathy.Methods The clinical data of 75 cases of cervical spondylotic myelopathy,which were performed anterior decompressive operation in our department during March 2000 to March 2002,are analyzed. According to the different drugs and their dose,patients are divided into four groups,namely,dexamethasone group(10mg),low-dose of methylprednisolone group (80mg),medium-dose of methylprednisolone group (160mg),high-dose of methylprednisolone group (1 000mg).The symptoms,the signs and the side-effects are observed respectively.Results The therapeutic effects of the high-dose of methylprednisolone group are better than those of the dexamethasone group and low-dose of methylprednisolone group(P0.01),and its side-effects are no more than the other groups(P0.05).Conclusion Methylprednisolone may reduce postoperative traumatic reaction of anterior decompressive operation of cervical spondylotic myelopathy.Appropriate high-dose of methylprednisolone (1 000mg) may achieve the effects we need clinically,meanwhile the side-effects don't increase.
What problem does this paper attempt to address?